Immuneering Corporation

IMRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$227,563$26,355$35,866$36,145
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,539$1,370$2,340$3,443
Total Curr. Assets$229,102$27,725$38,206$39,588
Property Plant & Equip (Net)$4,304$4,463$4,631$4,790
Goodwill$6,690$6,690$6,690$6,690
Intangibles$328$336$343$350
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$631$842$811$1,296
Total NC Assets$11,954$12,331$12,475$13,127
Other Assets$0$0$0$0
Total Assets$241,056$40,056$50,681$52,714
Liabilities
Payables$1,600$2,395$1,311$1,959
Short-Term Debt$382$367$353$338
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,563$4,725$3,445$5,207
Total Curr. Liab.$9,545$7,487$5,108$7,504
LT Debt$3,535$3,634$3,730$3,824
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,535$3,634$3,730$3,824
Other Liabilities$0$0$0$0
Cap. Leases$0$4,001$4,083$4,163
Total Liabilities$13,080$11,120$8,838$11,328
Equity
Pref Stock$0$0$0$0
Common Stock$63$36$36$31
Retained Earnings-$268,740-$253,775-$239,341-$224,295
AOCI$0$0$0$0
Other Equity$496,653$282,675$281,148$265,650
Total Equity$227,976$28,936$41,843$41,386
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$241,056$40,056$50,681$52,714
Net Debt-$223,647-$22,355-$31,783-$31,982
Immuneering Corporation (IMRX) Financial Statements & Key Stats | AlphaPilot